Robust pipeline with around 50 projects in clinical development / cardiology portfolio poised for growth with launch products Kerendia (finerenone) and Verquvo (vericiguat)
The COVID-19 pandemic has triggered the rapid growth of the biotherapeutics market
John served as General Manager for Catalent Pharma Solutions in St. Petersburg, Florida
Daewoong delivered KRW 1.055 trillion in sales, KRW 95.5 billion in operating profit and KRW 40.5 billion in net profit.
The SureSTART consumables portfolio is designed for higher performance requirements, while meeting customer budgets
The facility will manufacture its Herceptin biosimilar, Tuznue
Therapeutic use of the product is for short term symptomatic relief of colds, chills and influenza including chesty coughs
Essential products manufactured by Sartorius, using Sü dpack polymer films made from Dow resins, support safe and effective vaccine production for global vaccine supply
To be marketed by Strides Pharma Inc. in the US market
Subscribe To Our Newsletter & Stay Updated
